Sotylize Solution
Product Images NDC 24338-530

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotylize (NDC 24338-530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sotalol 01)

FDA Label Image

Chemical Structure (Sotalol 02)

FDA Label Image

Figure 2 (Sotalol 03)

FDA Label Image

Figure 3 (Sotalol 04)

FDA Label Image

Principal Display Panel (250 mL Bottle Label)

Principal Display Panel (250 mL Bottle Label)
This is a pharmaceutical product indicated for oral use only, containing the active ingredient bupropion hydrochloride. Its dosage instructions are contained in the package insert. The product comes in an oral solution form with a grape flavor and is packaged with sodium benzoate. If stored properly, the product remains effective until the expiration date. It is important to keep the product out of reach of children. This product is made in Canada and distributed by Arbor Pharmaceuticals. No further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.